Chemed Co. (NYSE:CHE) Insider Sells $1,990,020.00 in Stock

Chemed Co. (NYSE:CHE) insider Kevin J. Mcnamara sold 6,000 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $331.67, for a total value of $1,990,020.00. Following the completion of the sale, the insider now directly owns 159,334 shares of the company’s stock, valued at $52,846,307.78. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

NYSE:CHE traded up $1.40 during trading hours on Thursday, reaching $331.36. 94,464 shares of the stock were exchanged, compared to its average volume of 98,362. The company has a market cap of $5.26 billion, a P/E ratio of 27.78, a price-to-earnings-growth ratio of 2.96 and a beta of 1.18. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. Chemed Co. has a twelve month low of $260.03 and a twelve month high of $341.18.

Chemed (NYSE:CHE) last released its quarterly earnings data on Monday, April 29th. The company reported $2.92 EPS for the quarter, missing the consensus estimate of $2.96 by ($0.04). The company had revenue of $462.03 million during the quarter, compared to analyst estimates of $468.28 million. Chemed had a net margin of 11.37% and a return on equity of 35.19%. The company’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.72 EPS. As a group, analysts anticipate that Chemed Co. will post 12.65 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 19th. Stockholders of record on Thursday, May 30th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 0.36%. The ex-dividend date of this dividend is Wednesday, May 29th. Chemed’s payout ratio is presently 10.06%.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cerebellum GP LLC boosted its holdings in shares of Chemed by 10,000.0% in the 1st quarter. Cerebellum GP LLC now owns 1,010 shares of the company’s stock valued at $323,000 after buying an additional 1,000 shares during the last quarter. FMR LLC lifted its holdings in Chemed by 27.0% during the 1st quarter. FMR LLC now owns 311,951 shares of the company’s stock valued at $99,847,000 after purchasing an additional 66,276 shares during the last quarter. BlueMountain Capital Management LLC lifted its holdings in Chemed by 1,399.7% during the 1st quarter. BlueMountain Capital Management LLC now owns 40,537 shares of the company’s stock valued at $12,975,000 after purchasing an additional 37,834 shares during the last quarter. Covenant Partners LLC acquired a new stake in Chemed during the 1st quarter valued at $204,000. Finally, Jane Street Group LLC acquired a new stake in Chemed during the 1st quarter valued at $443,000. 87.92% of the stock is owned by institutional investors.

A number of research firms recently issued reports on CHE. Zacks Investment Research cut Chemed from a “hold” rating to a “sell” rating in a research note on Thursday, May 9th. Oppenheimer increased their target price on Chemed from $340.00 to $370.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 30th. Royal Bank of Canada increased their target price on Chemed from $313.00 to $318.00 and gave the stock a “sector perform” rating in a research note on Monday, February 25th. Finally, ValuEngine cut Chemed from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $347.00.

ILLEGAL ACTIVITY NOTICE: “Chemed Co. (NYSE:CHE) Insider Sells $1,990,020.00 in Stock” was reported by Rockland Register and is owned by of Rockland Register. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://rocklandregister.com/2019/05/30/chemed-co-che-insider-kevin-j-mcnamara-sells-6000-shares.html.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Read More: Cash Flow Analysis in Stock Selection

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.